{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:11:48Z","timestamp":1787667108106,"version":"build-2736575974"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.metabol.2025.156457","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:05:29Z","timestamp":1764201929000},"page":"156457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Molecular code of ferroptosis: emerging multi-dimensional modifications and therapeutic targets in hepatic disorders"],"prefix":"10.1016","volume":"175","author":[{"given":"Xiaotong","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10464","key":"10.1016\/j.metabol.2025.156457_bb0005","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.metabol.2025.156457_bb0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Hagstrom","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"155664","key":"10.1016\/j.metabol.2025.156457_bb0015","article-title":"From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need","volume":"147","author":"Kokkorakis","year":"2023","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.metabol.2025.156457_bb0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O","year":"2024","journal-title":"J Hepatol"},{"issue":"857892","key":"10.1016\/j.metabol.2025.156457_bb0025","article-title":"Identification of the non-alcoholic fatty liver disease molecular subtypes associated with clinical and immunological features via bioinformatics methods","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.metabol.2025.156457_bb0030","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","article-title":"The multifaceted roles of macrophages in NAFLD pathogenesis","volume":"15","author":"Vonderlin","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.metabol.2025.156457_bb0035","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.metabol.2025.156457_bb0040","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jhep.2025.02.003","article-title":"Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway","volume":"83","author":"Liu","year":"2025","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.metabol.2025.156457_bb0045","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1158\/1535-7163.MCT-23-0729","article-title":"SMG5 inhibition restrains hepatocellular carcinoma growth and enhances sorafenib sensitivity","volume":"23","author":"Fang","year":"2024","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13046-024-03039-2","article-title":"Augmented ERO1alpha upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11","volume":"43","author":"Wang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12935-021-02166-6","article-title":"Current understanding of ferroptosis in the progression and treatment of pancreatic cancer","volume":"21","author":"Dong","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"11","key":"10.1016\/j.metabol.2025.156457_bb0060","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"BRCC36 deubiquitinates HMGCR to regulate the interplay between ferroptosis and pyroptosis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"0281","key":"10.1016\/j.metabol.2025.156457_bb0065","article-title":"Hepatic HDAC3 regulates systemic iron homeostasis and ferroptosis via the hippo signaling pathway","volume":"6","author":"Meng","year":"2023","journal-title":"Research (Wash D C)"},{"issue":"6","key":"10.1016\/j.metabol.2025.156457_bb0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.2019002907","article-title":"Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.metabol.2025.156457_bb0075","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.7150\/ijbs.83348","article-title":"The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks","volume":"19","author":"Li","year":"2023","journal-title":"Int J Biol Sci"},{"issue":"7","key":"10.1016\/j.metabol.2025.156457_bb0080","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s43587-024-00652-w","article-title":"Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress","volume":"4","author":"Du","year":"2024","journal-title":"Nat Aging"},{"issue":"2","key":"10.1016\/j.metabol.2025.156457_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.metabol.2025.156457_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.metabol.2025.156457_bb0095","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.metabol.2025.156457_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202314710","article-title":"Strikingly high activity of 15-lipoxygenase towards Di-polyunsaturated arachidonoyl\/adrenoyl-phosphatidylethanolamines generates peroxidation signals of ferroptotic cell death","volume":"63","author":"Samovich","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40824-023-00401-x","article-title":"Fe(3+)-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma","volume":"27","author":"Xiao","year":"2023","journal-title":"Biomater Res"},{"issue":"167039","key":"10.1016\/j.metabol.2025.156457_bb0110","article-title":"Chronic cadmium exposure triggered ferroptosis by perturbing the STEAP3-mediated glutathione redox balance linked to altered metabolomic signatures in humans","volume":"905","author":"Deng","year":"2023","journal-title":"Sci Total Environ"},{"issue":"103328","key":"10.1016\/j.metabol.2025.156457_bb0115","article-title":"Synergistic induction of ferroptosis by targeting HERC1-NCOA4 axis to enhance the photodynamic sensitivity of osteosarcoma","volume":"76","author":"Zhang","year":"2024","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.metabol.2025.156457_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/15548627.2022.2084862","article-title":"Mitochondria ROS and mitophagy in acute kidney injury","volume":"19","author":"Su","year":"2023","journal-title":"Autophagy"},{"issue":"28","key":"10.1016\/j.metabol.2025.156457_bb0125","article-title":"Deubiquitinase OTUD5 as a novel protector against 4-HNE-triggered ferroptosis in myocardial ischemia\/reperfusion injury","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.metabol.2025.156457_bb0130","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.kint.2022.07.034","article-title":"Repression of the antiporter SLC7A11\/glutathione\/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification","volume":"102","author":"Ye","year":"2022","journal-title":"Kidney Int"},{"issue":"155953","key":"10.1016\/j.metabol.2025.156457_bb0135","article-title":"Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease","volume":"157","author":"Sui","year":"2024","journal-title":"Metabolism"},{"issue":"108373","key":"10.1016\/j.metabol.2025.156457_bb0140","article-title":"Molecular mechanisms of ferroptosis and their involvement in brain diseases","volume":"244","author":"Costa","year":"2023","journal-title":"Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.metabol.2025.156457_bb0145","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.7150\/thno.70194","article-title":"SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells","volume":"12","author":"Xuan","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","article-title":"Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-025-02269-y","article-title":"Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications","volume":"24","author":"Xie","year":"2025","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.metabol.2025.156457_bb0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41419-023-05840-x","article-title":"LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer","volume":"14","author":"Dai","year":"2023","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.metabol.2025.156457_bb0165","article-title":"N-glycosylation modification of CTSD affects liver metastases in colorectal cancer","volume":"12","author":"Xiong","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"10.1016\/j.metabol.2025.156457_bb0170","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.metabol.2025.156457_bb0175","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1080\/15548627.2019.1687985","article-title":"RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells","volume":"16","author":"Zhang","year":"2020","journal-title":"Autophagy"},{"issue":"103182","key":"10.1016\/j.metabol.2025.156457_bb0180","article-title":"O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells","volume":"73","author":"Zhou","year":"2024","journal-title":"Redox Biol"},{"issue":"124764","key":"10.1016\/j.metabol.2025.156457_bb0185","article-title":"YAP O-GlcNAcylation contributes to corneal epithelial cell ferroptosis under cigarette smoke exposure","volume":"360","author":"Zhang","year":"2024","journal-title":"Environ Pollut"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41392-022-01300-8","article-title":"Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets","volume":"8","author":"Shu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"35","key":"10.1016\/j.metabol.2025.156457_bb0195","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1039\/D3SC02350H","article-title":"A natural polyphenol activates and enhances GPX4 to mitigate amyloid-beta induced ferroptosis in Alzheimer\u2019s disease","volume":"14","author":"Baruah","year":"2023","journal-title":"Chem Sci"},{"issue":"8832043","key":"10.1016\/j.metabol.2025.156457_bb0200","article-title":"Posttranslational modifications in ferroptosis","volume":"2020","author":"Wei","year":"2020","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"10.1016\/j.metabol.2025.156457_bb0205","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/s41418-021-00859-z","article-title":"Organelle-specific regulation of ferroptosis","volume":"28","author":"Chen","year":"2021","journal-title":"Cell Death Differ"},{"issue":"102971","key":"10.1016\/j.metabol.2025.156457_bb0210","article-title":"Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma","volume":"69","author":"Li","year":"2024","journal-title":"Redox Biol"},{"issue":"102963","key":"10.1016\/j.metabol.2025.156457_bb0215","article-title":"Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO\/SLC7A11 pathway","volume":"68","author":"Jiang","year":"2023","journal-title":"Redox Biol"},{"issue":"155136","key":"10.1016\/j.metabol.2025.156457_bb0220","article-title":"Niujiao Dihuang Jiedu decoction promotes SLC7A11 m5C methylation modification against ferroptosis in acute-on-chronic liver failure","volume":"122","author":"Huang","year":"2024","journal-title":"Phytomedicine"},{"issue":"155289","key":"10.1016\/j.metabol.2025.156457_bb0225","article-title":"Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression","volume":"124","author":"Hu","year":"2024","journal-title":"Phytomedicine"},{"issue":"18","key":"10.1016\/j.metabol.2025.156457_bb0230","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.7150\/thno.99197","article-title":"Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism","volume":"14","author":"Zhao","year":"2024","journal-title":"Theranostics"},{"issue":"101181","key":"10.1016\/j.metabol.2025.156457_bb0235","article-title":"5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis","volume":"78","author":"Shi","year":"2025","journal-title":"Drug Resist Updat"},{"issue":"102546","key":"10.1016\/j.metabol.2025.156457_bb0240","article-title":"HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma","volume":"58","author":"Yuan","year":"2022","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-021-02208-x","article-title":"Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma","volume":"41","author":"Lu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0250","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1186\/s12951-024-02918-2","article-title":"Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment","volume":"22","author":"Qin","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"10.1016\/j.metabol.2025.156457_bb0255","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41419-022-05173-1","article-title":"LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13046-024-03061-4","article-title":"PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1\/miR-195-5p axis-dependent manner in hepatocellular carcinoma","volume":"43","author":"Li","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12943-024-02030-x","article-title":"CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p\/NUPR1\/FTH1 axis","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0270","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-024-02224-3","article-title":"CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p\/SLC7A11 axis","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"issue":"9","key":"10.1016\/j.metabol.2025.156457_bb0275","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41418-022-00970-9","article-title":"Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p\/MIOX axis as a ceRNA","volume":"29","author":"Zhang","year":"2022","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.metabol.2025.156457_bb0280","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12072-022-10459-9","article-title":"HMGCL-induced beta-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility","volume":"17","author":"Cui","year":"2023","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.metabol.2025.156457_bb0285","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","article-title":"Ubiquitination in the regulation of inflammatory cell death and cancer","volume":"28","author":"Cockram","year":"2021","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0290","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-00418-x","article-title":"Targeting the ubiquitination\/deubiquitination process to regulate immune checkpoint pathways","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.metabol.2025.156457_bb0295","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41419-023-06294-x","article-title":"Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.metabol.2025.156457_bb0300","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41418-022-00957-6","article-title":"Ubiquitin ligase E3 HUWE1\/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury","volume":"29","author":"Wu","year":"2022","journal-title":"Cell Death Differ"},{"issue":"8","key":"10.1016\/j.metabol.2025.156457_bb0305","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood.2020008986","article-title":"RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation","volume":"138","author":"Jiang","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0310","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","article-title":"SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma","volume":"30","author":"Chen","year":"2023","journal-title":"Cell Death Differ"},{"issue":"3","key":"10.1016\/j.metabol.2025.156457_bb0315","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41419-022-04708-w","article-title":"Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury","volume":"13","author":"Lin","year":"2022","journal-title":"Cell Death Dis"},{"issue":"31\u201348","key":"10.1016\/j.metabol.2025.156457_bb0320","article-title":"TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin\u2013proteasome system","volume":"219","author":"Zhang","year":"2024","journal-title":"Free Radic Biol Med"},{"issue":"245\u2013285","key":"10.1016\/j.metabol.2025.156457_bb0325","article-title":"Understanding the function of mammalian sirtuins and protein lysine acylation","volume":"90","author":"Wang","year":"2021","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0330","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12967-024-05404-3","article-title":"Mitochondrial GCN5L1 acts as a novel regulator for iron homeostasis to promote sorafenib sensitivity in hepatocellular carcinoma","volume":"22","author":"Hu","year":"2024","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.metabol.2025.156457_bb0335","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/liv.15936","article-title":"Loss of GCN5L1 exacerbates damage in alcoholic liver disease through ferroptosis activation","volume":"44","author":"Yang","year":"2024","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.metabol.2025.156457_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.852","article-title":"Mitochondrial GCN5L1 regulates glutaminase acetylation and hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Clin Transl Med"},{"issue":"7","key":"10.1016\/j.metabol.2025.156457_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1325","article-title":"Mitochondrial general control of amino acid synthesis 5 like 1 promotes nonalcoholic steatohepatitis development through ferroptosis-induced formation of neutrophil extracellular traps","volume":"13","author":"Lv","year":"2023","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0350","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41420-021-00468-2","article-title":"O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP\/TFRC pathway in liver cancer","volume":"7","author":"Zhu","year":"2021","journal-title":"Cell Death Discov"},{"issue":"135952","key":"10.1016\/j.metabol.2025.156457_bb0355","article-title":"Low-dose deoxynivalenol exposure triggers hepatic excessive ferritinophagy and mitophagy mitigated by hesperidin modulated O-GlcNAcylation","volume":"480","author":"Chen","year":"2024","journal-title":"J Hazard Mater"},{"issue":"33","key":"10.1016\/j.metabol.2025.156457_bb0360","article-title":"Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT","volume":"10","author":"Tang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"109384","key":"10.1016\/j.metabol.2025.156457_bb0365","article-title":"O-GlcNAcylated c-Jun antagonizes ferroptosis via inhibiting GSH synthesis in liver cancer","volume":"63","author":"Chen","year":"2019","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0370","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13045-024-01599-6","article-title":"METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"9","key":"10.1016\/j.metabol.2025.156457_bb0375","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41419-024-07054-1","article-title":"Impaired SUMOylation of FoxA1 promotes nonalcoholic fatty liver disease through down-regulation of Sirt6","volume":"15","author":"Zou","year":"2024","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.metabol.2025.156457_bb0380","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1080\/15548627.2019.1647944","article-title":"A fine-tuning mechanism underlying self-control for autophagy: deSUMOylation of BECN1 by SENP3","volume":"16","author":"Liu","year":"2020","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.metabol.2025.156457_bb0385","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.31881","article-title":"Hepatic small ubiquitin-related modifier (SUMO)-specific protease 2 controls systemic metabolism through SUMOylation-dependent regulation of liver-adipose tissue crosstalk","volume":"74","author":"Liu","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2025.156457_bb0390","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41418-020-00641-7","article-title":"Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury","volume":"28","author":"Huang","year":"2021","journal-title":"Cell Death Differ"},{"issue":"39\u201348","key":"10.1016\/j.metabol.2025.156457_bb0395","article-title":"NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis","volume":"466","author":"Guo","year":"2019","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.metabol.2025.156457_bb0400","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein arginine methyltransferases: promising targets for cancer therapy","volume":"53","author":"Hwang","year":"2021","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0405","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s12967-023-04408-9","article-title":"Arginine methylation of HSPA8 by PRMT9 inhibits ferroptosis to accelerate hepatitis B virus-associated hepatocellular carcinoma progression","volume":"21","author":"Deng","year":"2023","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.metabol.2025.156457_bb0410","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41556-023-01133-9","article-title":"Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function","volume":"25","author":"Wu","year":"2023","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0415","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12935-020-01689-8","article-title":"RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer","volume":"20","author":"Yang","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"101052","key":"10.1016\/j.metabol.2025.156457_bb0420","article-title":"Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma","volume":"73","author":"Hao","year":"2024","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0425","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41467-023-38753-6","article-title":"Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase","volume":"14","author":"Zhan","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.metabol.2025.156457_bb0430","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41418-024-01270-0","article-title":"APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy","volume":"31","author":"Du","year":"2024","journal-title":"Cell Death Differ"},{"issue":"12","key":"10.1016\/j.metabol.2025.156457_bb0435","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.7150\/thno.82132","article-title":"Protein phosphatase 2A-B55beta mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling","volume":"13","author":"Qian","year":"2023","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.metabol.2025.156457_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.747","article-title":"Tumour cells are sensitised to ferroptosis via RB1CC1-mediated transcriptional reprogramming","volume":"12","author":"Xue","year":"2022","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0445","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12951-024-02582-6","article-title":"Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma","volume":"22","author":"Dong","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"10.1016\/j.metabol.2025.156457_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1300","article-title":"Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation","volume":"13","author":"Shi","year":"2023","journal-title":"Clin Transl Med"},{"issue":"22","key":"10.1016\/j.metabol.2025.156457_bb0455","doi-asserted-by":"crossref","first-page":"22240","DOI":"10.1021\/acsnano.3c01199","article-title":"Long noncoding RNA URB1-antisense RNA 1 (AS1) suppresses sorafenib-induced ferroptosis in hepatocellular carcinoma by driving ferritin phase separation","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"issue":"155659","key":"10.1016\/j.metabol.2025.156457_bb0460","article-title":"Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: is there a role for statin therapy?","volume":"146","author":"Sahebkar","year":"2023","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metabol.2025.156457_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083852","article-title":"Ferroptosis in cancer: mechanism and therapeutic potential","volume":"26","author":"Singh","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.metabol.2025.156457_bb0470","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41419-023-05708-0","article-title":"Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities","volume":"14","author":"Miao","year":"2023","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0475","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11886-024-02181-9","article-title":"Metabolic dysfunction associated-steatotic liver disease (MASLD) and cardiovascular risk: embrace all facets of the disease","volume":"27","author":"Katsiki","year":"2025","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"10.1016\/j.metabol.2025.156457_bb0480","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1210\/jc.2015-3767","article-title":"Effect of hesperidin with and without a calcium (calcilock) supplement on bone health in postmenopausal women","volume":"101","author":"Martin","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"961892","key":"10.1016\/j.metabol.2025.156457_bb0485","article-title":"Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0490","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","article-title":"Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0495","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13054-016-1504-1","article-title":"N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial","volume":"20","author":"Fraga","year":"2016","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.metabol.2025.156457_bb0500","article-title":"Targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: safety and optimal dose selection in a randomized clinical trial","volume":"10","author":"Millan","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"10.1016\/j.metabol.2025.156457_bb0505","doi-asserted-by":"crossref","first-page":"909","DOI":"10.34067\/KID.0000000000000466","article-title":"Cardiac surgery-associated acute kidney injury","volume":"5","author":"Scurt","year":"2024","journal-title":"Kidney360"},{"issue":"Pt 3","key":"10.1016\/j.metabol.2025.156457_bb0510","article-title":"Nordihydroguaiaretic acid suppresses ferroptosis and mitigates intervertebral disc degeneration through the NRF2\/GPX4 axis","volume":"143","author":"Zhang","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"110538","key":"10.1016\/j.metabol.2025.156457_bb0515","article-title":"Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH)","volume":"498","author":"Han","year":"2019","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156457_bb0520","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12964-022-00849-9","article-title":"The activation of PPARgamma enhances Treg responses through up-regulating CD36\/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of TbetaRII\/IL-2Ralpha","volume":"20","author":"Miao","year":"2022","journal-title":"Cell Commun Signal"},{"issue":"5","key":"10.1016\/j.metabol.2025.156457_bb0525","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajog.2015.01.014","article-title":"Oxidative stress is responsible for maternal diabetes-impaired transforming growth factor beta signaling in the developing mouse heart","volume":"212","author":"Wang","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"123235","key":"10.1016\/j.metabol.2025.156457_bb0530","article-title":"Resveratrol alleviates Mono-2-ethylhexyl phthalate-induced mitophagy, ferroptosis, and immunological dysfunction in grass carp hepatocytes by regulating the Nrf2 pathway","volume":"371","author":"Wang","year":"2024","journal-title":"J Environ Manage"},{"issue":"109824","key":"10.1016\/j.metabol.2025.156457_bb0535","article-title":"Ferroptosis mediated by the interaction between Mfn2 and IREalpha promotes arsenic-induced nonalcoholic steatohepatitis","volume":"188","author":"Wei","year":"2020","journal-title":"Environ Res"},{"issue":"2","key":"10.1016\/j.metabol.2025.156457_bb0540","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/hep.23270","article-title":"Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial","volume":"51","author":"Ratziu","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.metabol.2025.156457_bb0545","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1148\/radiol.2016150719","article-title":"Prospective study of transcatheter arterial chemoembolization (TACE) with ginsenoside Rg3 versus TACE alone for the treatment of patients with advanced hepatocellular carcinoma","volume":"280","author":"Zhou","year":"2016","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.metabol.2025.156457_bb0550","article-title":"The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression","volume":"4","author":"Yan","year":"2023","journal-title":"MedComm (2020)"},{"issue":"6","key":"10.1016\/j.metabol.2025.156457_bb0555","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41419-023-05747-7","article-title":"USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through beta-catenin stabilization","volume":"14","author":"Tang","year":"2023","journal-title":"Cell Death Dis"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:22:11Z","timestamp":1781065331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525003269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":111,"alternative-id":["S0026049525003269"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156457","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular code of ferroptosis: emerging multi-dimensional modifications and therapeutic targets in hepatic disorders","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156457"}}